https://www.selleckchem.com/pr....oducts/fadraciclib.h
It is vital that their providers understand the frequency of these concerns as well as patients' preference for intervention. While HCT has become increasingly successful in treating hematologic cancers, many survivors experience a range of issues post-transplant. Survivorship care for these patients must include ongoing thorough assessment related to the practical, emotional, and medical symptoms experienced post-transplant, with appropriate intervention provided in-house where possible or in the community according to patient pref